[
    {
        "id": "jun-easy-1",
        "query": " Based on the charges associated with the Allergan acquisition integration plan, what was the total cost incurred by the company in 2023, and how does it compare to the costs in 2022?",
        "answer": "The total charges in 2023 were $288 millions, and 2023 charges are lower than 2022 charges by $251 millions.",
        "task_type": {
            "name": "complex_qa",
            "metrics": ["Success", "BLEU", "ROUGE"],
            "input_types": ["queries"],
            "output_types": ["text"]
        },
        "data_sources": ["<body><div style=\"min-height:45pt;width:100%\"><div><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">                                                         </span></div></div><ix:continuation id=\"f-786-2\"><ix:nonnumeric contextref=\"c-137\" escape=\"true\" id=\"f-788\" name=\"us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock\"><div style=\"margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">The following table summarizes the charges associated with the Allergan acquisition integration plan:</span><table style=\"border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%\"><tr><td style=\"width:1.0%\"></td><td style=\"width:31.209%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.530%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.572%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.384%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.581%\"></td><td style=\"width:0.1%\"></td></tr><tr><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">year ended December 31 (in millions)</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:center;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">2023</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:center;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">2022</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:center;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">2021</span></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><span style=\"-sec-ix-hidden:f-789\"><span style=\"-sec-ix-hidden:f-790\"><span style=\"-sec-ix-hidden:f-791\">Cost of products sold</span></span></span></span></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-138\" decimals=\"-6\" id=\"f-792\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">89</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-139\" decimals=\"-6\" id=\"f-793\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">117</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-140\" decimals=\"-6\" id=\"f-794\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">132</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Research and development</span></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-141\" decimals=\"-6\" id=\"f-795\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">7</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-142\" decimals=\"-6\" id=\"f-796\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">23</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-143\" decimals=\"-6\" id=\"f-797\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">102</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Selling, general and administrative</span></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-144\" decimals=\"-6\" id=\"f-798\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">192</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-145\" decimals=\"-6\" id=\"f-799\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">399</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-146\" decimals=\"-6\" id=\"f-800\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">353</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Total charges </span></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt\"></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-147\" decimals=\"-6\" id=\"f-801\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">288</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-148\" decimals=\"-6\" id=\"f-802\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">539</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-149\" decimals=\"-6\" id=\"f-803\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">587</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr></table></div></ix:nonnumeric><ix:nonnumeric contextref=\"c-137\" escape=\"true\" id=\"f-804\" name=\"us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock\"><div style=\"margin-bottom:8pt;margin-top:10pt;text-indent:24.75pt\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">The following table summarizes the cash activity in the recorded liability associated with the integration plan: </span><table style=\"border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%\"><tr><td style=\"width:1.0%\"></td><td style=\"width:76.239%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.864%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.1%\"></td><td style=\"width:0.530%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:9.867%\"></td><td style=\"width:0.1%\"></td></tr><tr><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">year ended December 31 (in millions)</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2020</span></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt\"></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-150\" decimals=\"-6\" id=\"f-805\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">387</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-149\" decimals=\"-6\" id=\"f-806\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">526</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-149\" decimals=\"-6\" id=\"f-807\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">658</ix:nonfraction>)</span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2021</span></td><td colspan=\"3\" style=\"background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-151\" decimals=\"-6\" id=\"f-808\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">255</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-148\" decimals=\"-6\" id=\"f-809\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">377</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-148\" decimals=\"-6\" id=\"f-810\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">525</ix:nonfraction>)</span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2022</span></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-152\" decimals=\"-6\" id=\"f-811\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">107</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges </span></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-147\" decimals=\"-6\" id=\"f-812\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">274</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#cceeff;padding:0 1pt\"></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-147\" decimals=\"-6\" id=\"f-813\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">338</ix:nonfraction>)</span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2023</span></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt\"></td><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt\"></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-153\" decimals=\"-6\" id=\"f-814\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">43</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr></table></div></ix:nonnumeric><div style=\"margin-bottom:8pt;margin-top:8pt\"><span style=\"color:#444867;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%\">Other Restructuring</span></div><div style=\"margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">AbbVie continuously evaluates its operations to identify opportunities to optimize its manufacturing and R&amp;D operations, commercial infrastructure and administrative costs and to respond to changes in its business environment. As a result, AbbVie management periodically approves individual restructuring plans to achieve these objectives. In 2023, 2022 and 2021, no such plans were individually significant. Restructuring charges recorded were $<ix:nonfraction contextref=\"c-154\" decimals=\"-6\" format=\"ixt:num-dot-decimal\" id=\"f-815\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">132</ix:nonfraction> million in 2023, $<ix:nonfraction contextref=\"c-155\" decimals=\"-6\" format=\"ixt:num-dot-decimal\" id=\"f-816\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">241</ix:nonfraction> million in 2022 and $<ix:nonfraction contextref=\"c-156\" decimals=\"-6\" format=\"ixt:num-dot-decimal\" id=\"f-817\" name=\"us-gaap:RestructuringAndRelatedCostIncurredCost\" scale=\"6\" unitref=\"usd\">59</ix:nonfraction> million in 2021 and were primarily related to employee severance and contractual obligations. These charges were recorded in cost of products sold, R&amp;D expense and SG&amp;A expenses in the consolidated statements of earnings based on the classification of the affected employees or operations.</span></div><ix:nonnumeric contextref=\"c-157\" escape=\"true\" id=\"f-818\" name=\"us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock\"><div style=\"margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">The following table summarizes the cash activity in the restructuring reserve for 2023, 2022 and 2021:</span></div><div style=\"margin-bottom:8pt;margin-top:8pt\"><table style=\"border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%\"><tr><td style=\"width:1.0%\"></td><td style=\"width:86.162%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:11.638%\"></td><td style=\"width:0.1%\"></td></tr><tr><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%\">(in millions)</span></td><td colspan=\"3\" style=\"padding:0 1pt\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2020</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-158\" decimals=\"-6\" id=\"f-819\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">90</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><div><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></div></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-159\" decimals=\"-6\" id=\"f-820\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">54</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-159\" decimals=\"-6\" id=\"f-821\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">111</ix:nonfraction>)</span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2021</span></td><td colspan=\"2\" style=\"background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-160\" decimals=\"-6\" id=\"f-822\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">33</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><div><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></div></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-161\" decimals=\"-6\" id=\"f-823\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">193</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-161\" decimals=\"-6\" id=\"f-824\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">50</ix:nonfraction>)</span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2022</span></td><td colspan=\"2\" style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-162\" decimals=\"-6\" id=\"f-825\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">176</ix:nonfraction> </span></td><td style=\"background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><div><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Charges</span></div></td><td colspan=\"2\" style=\"background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-157\" decimals=\"-6\" id=\"f-826\" name=\"abbv:RestructuringReserveCashSettledRestructuringGainsLosses\" scale=\"6\" unitref=\"usd\">107</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Payments and other adjustments</span></td><td colspan=\"2\" style=\"background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">(<ix:nonfraction contextref=\"c-157\" decimals=\"-6\" id=\"f-827\" name=\"abbv:RestructuringReservePeriodCashSettledAndOtherAdjustments\" scale=\"6\" unitref=\"usd\">87</ix:nonfraction>)</span></td><td style=\"background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr><tr><td colspan=\"3\" style=\"background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">Accrued balance as of December 31, 2023</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">$</span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\"><ix:nonfraction contextref=\"c-163\" decimals=\"-6\" id=\"f-828\" name=\"us-gaap:RestructuringReserve\" scale=\"6\" unitref=\"usd\">196</ix:nonfraction> </span></td><td style=\"background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom\"></td></tr></table></div></ix:nonnumeric></ix:continuation><div style=\"height:45pt;position:relative;width:100%\"><div style=\"bottom:0;position:absolute;width:100%\"><div style=\"text-align:center\"><table style=\"border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%\"><tr><td style=\"width:1.0%\"></td><td style=\"width:32.233%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:27.681%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:32.673%\"></td><td style=\"width:0.1%\"></td><td style=\"width:1.0%\"></td><td style=\"width:3.013%\"></td><td style=\"width:0.1%\"></td></tr><tr><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:0 1pt\"></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:middle\"><div style=\"text-align:right\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%\">2023 Form 10-K</span><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%\">   |  </span><img alt=\"abbvieimage3.gif\" src=\"abbv-20231231_g2.gif\" style=\"height:13px;margin-bottom:5pt;vertical-align:text-bottom;width:70px\"/></div></td><td colspan=\"3\" style=\"padding:2px 1pt;text-align:left;vertical-align:bottom\"><div style=\"text-align:right\"><span style=\"color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%\">68</span></div></td></tr></table></div></div></div><div id=\"i891ae87e1630411bb99f581d920680e3_139\"></div></body>"],        
        "data_modalities": [ "" ],
        "subtasks": [{
            "id": "jun-easy-1-1",
            "query": "What were the total charges associated with the Allergan acquisition integration plan in 2023?",
            "answer": "The total charges in 2023 were $288 millions",
            "task_type": {
                "name": "extraction",
                "metrics": ["Success"],
                "input_types": ["queries"],
                "output_types": ["text"]
            },
            "data_sources": [ "" ],
            "data_modalities": [ "" ]
        },
        {
            "id": "jun-easy-1-2",
            "query": "How do the total charges associated with the Allergan acquisition integration plan in 2023 compared to that of 2022?",
            "answer": "2023 charges are lower than 2022 charges by $251 millions.",
            "task_type": {
                "name": "extraction",
                "metrics": ["Success"],
                "input_types": ["queries"],
                "output_types": ["text"]
            },
            "data_sources": [ "" ],
            "data_modalities": [ "" ]
        }]
    }
]